Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: a meta-analysis of 59 trials
P.M. Burger(University Medical Center Utrecht), Frank L.J. Visseren, S Koudstaal, Arend Mosterd(Werkgroep Cardiologische centra Nederland), Jannick A N Dorresteijn(Heidelberg University)
Cited by 3
Related Papers
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2021|6.1k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
rab3 is a small GTP-binding protein exclusively localized to synaptic vesicles.
|Proceedings of the National Academy of Sciences|1990|492
Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population
|Circulation|2016|275
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
|Cardiovascular Diabetology|2021|204